Plant Health Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 0.26 M
- Paid Up Capital ₹ 0.26 M
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 5.45 M
- Revenue Growth 33.18%
- Profit Growth 77.23%
- Ebitda 20.88%
- Net Worth 8.37%
- Total Assets 17.89%
About Plant Health Biotechnologies
Plant Health Biotechnologies Private Limited (PHBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 June 2014 and has a history of Ten years and seven months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.26 M and a paid-up capital of Rs 0.26 M.
The company has closed loans amounting to ₹5.45 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pramod Nagpure and Lata Nagpure serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24301PN2014PTC151403
-
Company No.
151403
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Jun 2014
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Plant Health Biotechnologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramod Nagpure
|
Director | 09-Jun-2014 | Current |
|
Lata Nagpure
|
Additional Director | 26-May-2022 | Current |
Financial Performance of Plant Health Biotechnologies.
Plant Health Biotechnologies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 33.18% increase. The company also saw a substantial improvement in profitability, with a 77.23% increase in profit. The company's net worth moved up by a moderate rise of 8.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plant Health Biotechnologies?
In 2019, Plant Health Biotechnologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹5.45 M
Charges Breakdown by Lending Institutions
- Others : 0.55 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2018 | Others | ₹1.00 M | Satisfied |
| 10 Oct 2016 | Others | ₹2.00 M | Satisfied |
| 10 Oct 2016 | Others | ₹2.45 M | Satisfied |
How Many Employees Work at Plant Health Biotechnologies?
Unlock and access historical data on people associated with Plant Health Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plant Health Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plant Health Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
